WN
MDXG icon

Williams & Novak’s MiMedx Group MDXG Stock Holding History

Williams & Novak’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-13,884
Closed -$53.5K – 154
2026
Q2 		$53.5K Buy
+13,884
New +$50.7K 0.04% 137

Other funds holding MDXG

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Williams & Novak's MDXG Position: Q3 2026 in Review

Williams & Novak sold out of MiMedx Group (MDXG) in Q3 2026, closing a stake of 13,884 shares — an estimated $53.5K sold.

Williams & Novak first reported a position in MDXG in Q2 2026 and held it in 1 quarter. The position peaked at $53.5K in Q2 2026. 5 funds tracked by Wall St. Rank hold MDXG as of Q3 2026.

  • Williams & Novak reported no remaining MiMedx Group position as of Q3 2026 after selling out during the quarter.
  • Williams & Novak sold 13,884 MiMedx Group shares in Q3 2026, an estimated $53.5K.
  • Williams & Novak first reported a position in MiMedx Group in Q2 2026 and held it in 1 quarter.
  • Williams & Novak's MiMedx Group position peaked at $53.5K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2026.

Based on Williams & Novak's 13F filing for Q3 2026, filed 9 Oct 2026.